Searched for
TRANSDERMAL MANUFACTURING SITE
Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’Businesses that create long-term wealth are those where the demand runway is long, the competitive position is strong, and the management i...- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Possibility and probability favour them in war and peace: 10 large-cap stocks from 2 sectors with upside potential of up to 28%Probability theory is important in the stock market. Reason: Stock prices are a function of many factors and the underlying operating matri...
- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
- With the tariff threat headache over, time to focus on them again? 8 pharma stocks with upside potential of up to 39%With a clear indication that no additional or special tariff will be imposed by the US on generic drugs, there is a sense of relief among I...
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matt...
- These large- and mid-cap stocks can give more than 48% return in 1 year, according to analystsIt is not often that the stock market heads to the Union budget with the kind of correction it has seen in recent months. Normally, there a...
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
- Zydus eyes M&A, licensing to build its US specialty businessZydus Lifesciences is exploring mergers, acquisitions, and licensing to bolster its specialty portfolio in the US, particularly for the pot...
- These large-caps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 29%It might be a bit too early to say, but the way things panned out during Monday's trade suggests the worst may be over for the bulls. A typ...
- Trump & Tariffs: Pharma sector might escape the inevitable tariff troubles. 6 pharma stocks, 5 with an upside potential of up to 38%Exactly eight years ago, in 2016, when a reality TV star became US president, the global markets went into sharp decline on the day of surp...
- Zydus Lifesciences gets USFDA nod to market Scopolamine transdermal systemZydus Lifesciences Ltd has received USFDA approval to market its Scopolamine transdermal system, which helps prevent nausea and vomiting un...
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...
- These 5 pharma stocks can give more than 24% returns in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- Intent of global acquisitions, has the tide turned for the long term? 5 pharma stocks with upside potential of up to 31 %Just yesterday, there was a news report which suggested that the French government is planning to block the sale of a French generic drug m...
- Defensive bet with macro tailwinds? 5 Indian pharma stocks with upside potential of up to 20%On Tuesday, when the whole market was reeling under pressure, two stocks reacted to their numbers in a positive direction. Both of them wer...
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
Load More
